tiprankstipranks
Trending News
More News >
Acurx Pharmaceuticals (ACXP)
NASDAQ:ACXP
US Market

Acurx Pharmaceuticals (ACXP) Income Statement

Compare
169 Followers

Acurx Pharmaceuticals Income Statement

Last quarter (Q3 2024), Acurx Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Acurx Pharmaceuticals's net income was $-2.82B. See Acurx Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 14.10B$ 14.58M$ 12.09M$ 12.81M$ 4.60M
Depreciation and Amortization
$ 0.00$ 14.58M$ 12.09M$ 12.81M$ 4.60M
EBITDA
$ 0.00$ 0.00$ -12.09M$ 0.00$ -4.60M
Operating Income
$ 0.00$ -14.58M$ -12.09M$ -12.88M$ -4.60M
Other Income/Expenses
$ 0.00$ 0.00$ -1.00$ 66.50K$ 0.00
Pretax Income
$ -14.10B$ -14.58M$ -12.09M$ -12.75M$ -4.60M
Net Income
$ -14.10B$ -14.58M$ -12.09M$ -12.68M$ -4.60M
Per Share Metrics
Basic EPS
$ -872.54$ -1.15$ -1.12$ -1.24$ -0.46
Diluted EPS
$ -872.54$ -1.15$ -1.12$ -1.24$ -0.46
Weighted Average Shares Outstanding
16.16M 12.67M 10.82M 10.22M 9.92M
Weighted Average Shares Outstanding (Diluted)
16.16M 12.67M 10.82M 10.22M 9.92M
Currency in USD

Acurx Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis